Episode

Why Neurotech Is at an "AI in 2016" Moment | Varun Turlapati, Chaanakya Capital

Podcast
Top Decile Podcast
Published
May 8, 2026
Duration seconds
1325
Processing state
not_requested
Canonical source
https://api.riverside.com/hosting-analytics/media/e474b9630d7c06fa6b98457896e26a468c3a80ecab6fbdd60808edea6f300926/eyJlcGlzb2RlSWQiOiJjODQ4ZDMzNi1hMDg0LTQ0MmQtOTdiNi04NTg3Y2Y5MDNhYjkiLCJwb2RjYXN0SWQiOiJmOGJlZWFlOC0wMDgzLTQ3NzktYmVlMy01YjRhMjdjYzIyMmYiLCJhY2NvdW50SWQiOiI2OWMxNGUxYTM1ZDgwNDA3YmViYmZmNjciLCJwYXRoIjoibWVkaWEvY2xpcHMvNjlmYjE4MDA4YWMzN2U5MjI2YjI4ZjI0L2Nvbm5vci1zYXR0ZWx5cy1zdHVkaW8tY29tcG9zZXItMjAyNi01LTZfXzEyLTI5LTIwLm1wMyJ9.mp3
Audio
https://api.riverside.com/hosting-analytics/media/e474b9630d7c06fa6b98457896e26a468c3a80ecab6fbdd60808edea6f300926/eyJlcGlzb2RlSWQiOiJjODQ4ZDMzNi1hMDg0LTQ0MmQtOTdiNi04NTg3Y2Y5MDNhYjkiLCJwb2RjYXN0SWQiOiJmOGJlZWFlOC0wMDgzLTQ3NzktYmVlMy01YjRhMjdjYzIyMmYiLCJhY2NvdW50SWQiOiI2OWMxNGUxYTM1ZDgwNDA3YmViYmZmNjciLCJwYXRoIjoibWVkaWEvY2xpcHMvNjlmYjE4MDA4YWMzN2U5MjI2YjI4ZjI0L2Nvbm5vci1zYXR0ZWx5cy1zdHVkaW8tY29tcG9zZXItMjAyNi01LTZfXzEyLTI5LTIwLm1wMyJ9.mp3
JSON
/v1/public/podcasts/top-decile-podcast-7851283/episodes/why-neurotech-is-at-an-ai-in-2016-moment-varun-turlapati-chaanakya-capital
Markdown
/podcast/top-decile-podcast-7851283/why-neurotech-is-at-an-ai-in-2016-moment-varun-turlapati-chaanakya-capital.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/top-decile-podcast-7851283/episodes/why-neurotech-is-at-an-ai-in-2016-moment-varun-turlapati-chaanakya-capital/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/top-decile-podcast-7851283/why-neurotech-is-at-an-ai-in-2016-moment-varun-turlapati-chaanakya-capital.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

Varun Turlapati spent 16 years as a software engineer before founding Chaanakya Capital, a $2M pre-seed fund backing US neurotech and medtech startups. His edge is his master's in electrical and computer engineering. He can evaluate the science-heavy deals most VCs don't even understand. Find out why neurotech is at the same inflection point AI was in 2016. Hear how one company puts a bionic hand on both amputees and robotic arms for hazardous industrial environments. And discover why Varun is focused on entering early in a field where others prefer to wait for de-risking.